# Phase III Study of Ranimustine, Cyclophosphamide, Vincristine, Melphalan, and Prednisolone (MCNU-COP/MP) versus Modified COP/MP in Multiple Myeloma: A Japan Clinical Oncology Group Study, JCOG 9301

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/phase-iii-study-of-ranimustine-cyclophosphamide-vincristine-melphalan-and/

## Facts

| Field | Value |
| --- | --- |
| Author Names | T Takenaka,Kuniaki Itoh,Takayo Suzuki,Atae Utsunomiya,Shin Matsuda,Takaaki Chou,Toshiaki Sai,Masayuki Sano,Susumu Konda,Tatsuji Ohno,C Mikuni,Kijoh Deura,Takashi Yamada,F Mizorogi,H Nagoshi,Masao Tomonaga,Tomomitsu Hotta,Kohichi Kawano,Keitaro Tsushita,Masami Hirano,M Shimoyama,Lymphoma Study Group |
| Citations | 9 |
| DOI | 10.1532/ijh97.03115 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W1972009112 |
| PMID | 15005346 |
| Type | article |
| Year | 2004 |

## Paper authors

- [F Mizorogi](https://scholariq.org/researchers/f-mizorogi/)

## Paper journal

- [International Journal of Hematology](https://scholariq.org/journals/international-journal-of-hematology/)

## Paper primary topic

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)

## Paper topics

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Cancer therapeutics and mechanisms](https://scholariq.org/topics/cancer-therapeutics-and-mechanisms/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.